Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,741,431
+$5,737,564 QoQ
Shares Held
313,397
+131028.5% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ERAS ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,741,431 | 313,397 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,867 | 239 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,621 | 5,006 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,457,886 | 668,756 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $768,844 | 605,390 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $16,164 | 11,799 | Shares | Sole | 2025-11-21 | |
| 2024-12-31 | $58,111 | 23,152 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $51,014 | 18,687 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $494,684 | 209,612 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $3,901 | 1,894 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $53,924 | 25,317 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,691 | 13,549 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,233 | 8,418 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,172 | 4,044 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,674 | 7,349 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,177 | 792 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,038 | 366 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $279,000 | 32,442 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $67,071 | 4,305 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,187 | 2,318 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||